Buys
Open market- Shares
- Avg price
- Total value
Michael Geffner - Chief Medical Officer at Immunovant, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- IMVT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Michael Geffner in Immunovant, Inc.
Sells
Open market- Shares
- -7,412
- Avg price
- $18.00
- Total value
- -$133,403
Net
Past year- Shares
- -7,412
- Share %
- -100%
- Total value
- -$133,403
Reported holdings for Michael Geffner in Immunovant, Inc.
Form 4 holding
Chief Medical Officer
Immunovant, Inc.
- Security class
- Common Stock
- Shares / value
- 217,958
- Estimated value
- $4,147,740
- Report date
- 22 Oct 2025
- Price
- $19.03
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
Immunovant, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 143,063
- Estimated value
- Report date
- 01 Apr 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael Geffner in Immunovant, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.